WallStreetZenWallStreetZen

NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CNSP stock forecasts and price targets.

Forecast return on equity

Is CNSP forecast to generate an efficient return?

Company
-60.94%
Industry
27.52%
Market
153.68%
CNSP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CNSP forecast to generate an efficient return on assets?

Company
-31.96%
Industry
3.45%
CNSP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CNSP earnings per share forecast

What is CNSP's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$3.74
Avg 2 year Forecast
-$2.95
Avg 3 year Forecast
-$3.40

CNSP revenue forecast

What is CNSP's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

CNSP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNSP$2.31N/AN/A
PBM$6.25N/AN/A
SLXN$0.60$6.00+903.34%Strong Buy
INM$0.72N/AN/A
PPCB$0.10N/AN/A
View Top Biotech Stocks

Cns Pharmaceuticals Stock Forecast FAQ

What is CNSP's earnings growth forecast for 2026-2028?

(NASDAQ: CNSP) Cns Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.6%.

Cns Pharmaceuticals's earnings in 2026 is -$15,850,564.On average, 4 Wall Street analysts forecast CNSP's earnings for 2026 to be -$3,037,578, with the lowest CNSP earnings forecast at -$2,918,457, and the highest CNSP earnings forecast at -$3,126,919. On average, 4 Wall Street analysts forecast CNSP's earnings for 2027 to be -$2,391,989, with the lowest CNSP earnings forecast at -$2,298,186, and the highest CNSP earnings forecast at -$2,462,342.

In 2028, CNSP is forecast to generate -$2,756,168 in earnings, with the lowest earnings forecast at -$2,648,083 and the highest earnings forecast at -$2,837,231.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.

What is CNSP's revenue growth forecast for 2026-2028?

(NASDAQ: CNSP) Cns Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 50.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.14%.

Cns Pharmaceuticals's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast CNSP's revenue for 2026 to be $0, with the lowest CNSP revenue forecast at $0, and the highest CNSP revenue forecast at $0. On average, 3 Wall Street analysts forecast CNSP's revenue for 2027 to be $0, with the lowest CNSP revenue forecast at $0, and the highest CNSP revenue forecast at $0.

In 2028, CNSP is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is CNSP's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: CNSP) forecast ROA is -31.96%, which is lower than the forecast US Biotechnology industry average of 3.45%.

What is CNSP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CNSP) Cns Pharmaceuticals's current Earnings Per Share (EPS) is -$35.75. On average, analysts forecast that CNSP's EPS will be -$3.74 for 2026, with the lowest EPS forecast at -$3.60, and the highest EPS forecast at -$3.85. On average, analysts forecast that CNSP's EPS will be -$2.95 for 2027, with the lowest EPS forecast at -$2.83, and the highest EPS forecast at -$3.03. In 2028, CNSP's EPS is forecast to hit -$3.40 (min: -$3.26, max: -$3.50).

What is CNSP's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: CNSP) forecast ROE is -60.94%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.